Los diamantes siempre han ocupado un lugar destacado debido a su belleza, durabilidad y rareza. Sin embargo, en las últimas décadas, la aparición de los diamantes sintéticos ha revolucionado la industria, desafiando las percepciones tradicionales sobre estas codiciadas pi …
¿Qué son los diamantes sintéticos y cómo se obtienen? Read More »
2seventy bio, Inc., announced the completion of the asset purchase agreement by Regeneron Pharmaceuticals, Inc. Under the terms of the APA, Regeneron has acquired all oncology and autoimmune research and development programs and has hired approximately 160 employees from 2seventy bio as part of their newly launched cell medicines business.
Zai Lab Limited partner Bristol Myers Squibb announced the pivotal Phase 3 KRYSTAL-12 study, evaluating KRAZATI® as a monotherapy in patients with pretreated locally advanced or metastatic non-small cell lung cancer harboring a KRASG12C mutation, met the primary endpoint of progression-free survival and the key secondary endpoint of overall response rate as assessed by Blinded
Antibe Therapeutics Inc. announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration that otenaproxesul has been placed on clinical hold, postponing the initiation of the planned Phase II trial.
Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance Read More »
Es una enfermedad febril con manifestaciones clínicas que varían desde una infección asintomática hasta una infección grave con disfunción multiorgánica.
Impacto global, inmunofisiopatología y clínica | Dengue Read More »
VOYDEYA™ (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular hemolysis (EVH) in adults with paroxysmal nocturnal hemoglobinuria (PNH).
Grants to be awarded to early-career scientists for pioneering research in immunology, vaccine discovery, and immunotherapy research
Baxter International Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform – which includes Baxter’s syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity
Rapafusyn Pharmaceuticals is pleased to announce two upcoming presentations at Cambridge Health Institute’s 12th Annual Oral Peptides & Macrocyclics Conference, April 1 – 4 in San Diego.
The activist shareholder seeks two more seats on Masimo’s board, after both candidates it nominated last spring were voted in.
Masimo faces another proxy challenge from Politan Capital Read More »
